The value of plasmonic sensors in achieving higher sensitivity and practicality—especially in cancer biomarker detection—is highlighted by recent promising findings emanating from VEGF biosensor setups such as Raman Spectroscopes and Luminescence Complexes with integrated plasmonic signal enhancement [21,22]. The gene discussed is VEGFA; the disease is cancer.